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Abstract
Transgenic crops that produce Bacillus thuringiensis (Bt) toxins are grown widely for pest control,1
but insect adaptation can reduce their efficacy.2–6 The genetically modified Bt toxins Cry1AbMod and
Cry1AcMod were designed to counter insect resistance to native Bt toxins Cry1Ab and Cry1Ac.7
Previous results suggested that the modified toxins would be effective only if resistance was linked
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with mutations in genes encoding toxin-binding cadherin proteins.7 Here we report evidence from
five major crop pests refuting this hypothesis. Relative to native toxins, the potency of modified toxins was >350-fold higher against resistant strains of Plutella xylostella and Ostrinia nubilalis in which
resistance was not linked with cadherin mutations. Conversely, the modified toxins provided little
or no advantage against some resistant strains of three other pests with altered cadherin. Independent of the presence of cadherin mutations, the relative potency of the modified toxins was generally
higher against the most resistant strains.

The toxins produced by Bt kill some major insect pests but cause little or no harm to people
and most other organisms.8 Bt toxins have been used in sprays for decades and in transgenic plants since 1996 (ref. 6). Transgenic corn and cotton producing Bt toxins were
planted on >58 million hectares worldwide in 2010 (ref. 1). The primary threat to the longterm efficacy of Bt toxins is the evolution of resistance by pests.2–6 Many insects have been
selected for resistance to Bt toxins in the laboratory, and some populations of at least eight
crop pests have evolved resistance to Bt toxins outside of the laboratory, including two
species resistant to Bt sprays and at least six species resistant to Bt crops.2–6,9–13
The most widely used Bt toxins are crystalline proteins in the Cry1A family, particularly
Cry1Ab in transgenic Bt corn and Cry1Ac in transgenic Bt cotton, which kill some lepidopteran larvae.3 Cry1A toxins bind to the extracellular domains of cadherin, aminopeptidase,
and alkaline phosphatase in larval midgut membranes.14,15 Disruption of Bt toxin binding
to midgut receptors is the most common general mechanism of insect resistance.9 Mutations in the genes encoding midgut cadherins that bind Cry1Ac are linked with resistance
in at least three lepidopteran pests of cotton,16–18 but such cadherin mutations are not the
primary cause of many other cases of field- and laboratory-selected resistance.9,19,20
Although some aspects of the mode of action of Bt toxins remain unresolved, extensive
evidence shows that after Cry1A protoxins are ingested by larvae, they are solubilized in
the gut and cleaved by mid-gut proteases such as trypsin to yield activated 60-kD monomeric toxins that bind with membrane-associated receptors.14,15 The signaling model suggests that after protease-activated monomeric toxins bind to cadherin, initiation of a
magnesium-dependent signaling pathway causes cell death.14,15 In contrast, a recent version of the pore formation model21 proposes the following sequence of events: proteaseactivated monomers bind to glycosylphosphatidylinositol (GPI)-anchored proteins, including aminopeptidases and alkaline phosphatases. This interaction promotes binding of
toxin monomers to cadherin, which facilitates protease cleavage of the N terminus of the
toxin, including helix α-1 of domain I, inducing oligomerization of the toxin. The toxin
oligomers bind with increased affinity to GPI-anchored receptors and create pores in the
midgut membrane that cause osmotic shock and cell death.
According to the pore formation model, the binding of protease-activated toxin to cadherin is essential for removal of helix α-1, which in turn promotes oligomerization.7 Therefore, we hypothesized that genetically modified Cry1Ab and Cry1Ac toxins (Cry1AbMod
and Cry1AcMod) lacking helix α-1 could form oligomers without cadherin and kill insects
in which cadherin was altered or absent. Consistent with this hypothesis, Cry1AbMod and
Cry1AcMod formed oligomers capable of in vitro pore formation in the absence of cadherin, whereas Cry1Ab and Cry1Ac did not.7,22 Moreover, the modified toxins killed larvae
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with reduced susceptibility to native Cry1A toxins caused by RNA interference silencing
of the cadherin gene in Manduca sexta and by naturally occurring deletion mutations in the
cadherin gene of resistant Pectinophora gossypiella.7 Although these results suggested the
potential utility of modified toxins for countering cadherin-based resistance, it remained
unclear if the modified toxins would be useful against cadherin-based resistance in other
species or against resistance caused by other mutations. Here we used laboratory bioassays
to compare responses to modified and native Bt toxins by 12 resistant and susceptible
strains of five species of major crop pests (P. xylostella, O. nubilalis, Diatraea saccharalis, Helicoverpa armigera, and Heliothis virescens) with various genetic mechanisms of resistance (see
Methods section and Supplementary Table 1).
Cry1AbMod and Cry1AcMod strikingly reduced resistance in the field-selected resistant strain (NO-QAGE) of P. xylostella (Figs. 1 and 2 and Supplementary Table 2). We
calculated the resistance ratio as the concentration of toxin killing 50% of larvae (LC50) for
a resistant strain divided by the LC50 for a conspecific susceptible strain. For the resistant
strain of P. xylostella, the resistance ratios were >21,000 for Cry1Ab, 3.1 for Cry1AbMod,
>110,000 for Cry1Ac, and 4.8 for Cry1AcMod (Fig. 2). We measured the reduction in resistance ratio for the modified toxin relative to its native counterpart as the resistance ratio
for the native toxin divided by the resistance ratio for the corresponding modified toxin.
The resistance ratio was reduced by a factor of >6,900 for Cry1AbMod relative to Cry1Ab
and >23,000 for Cry1AcMod relative to Cry1Ac (Supplementary Table 2).

Figure 1. Responses of susceptible and resistant strains of P. xylostella to native and genetically modified Bt toxins: (a) Cry1Ab, (b) Cry1AbMod, (c) Cry1Ac, and (d) Cry1AcMod.
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Figure 2. Resistance to native Bt toxins Cry1Ab and Cry1Ac (light bars) and genetically
modified Bt toxins Cry1AbMod and Cry1AcMod (dark bars) in six species of insect pests.
Data are reported here for P. xylostella (Px), O. nubilalis (On), D. saccharalis (Ds), and H.
armigera (Ha) (Supplementary Table 2) and were reported previously for P. gossypiella
(Pg)7 and T. ni (Tn).10 Resistance ratios are the concentration of toxin killing 50% of larvae
(LC50) for each resistant strain divided by the LC50 for the conspecific susceptible strain.
The arrows pointing up indicate resistance ratios higher than the top of the bar that cannot
be estimated precisely because mortality of the resistant strains of Px and Pg against native toxins was so low that we could not accurately estimate LC50 values. The arrow pointing down indicates a resistance ratio <1 (0.41) for Cry1AcMod versus Pg.7

Results with laboratory-selected resistant strains of three other major crop pests (KS, O.
nubilalis; Bt-RR, D. saccharalis; and SCD-r1, H. armigera) were qualitatively similar to those
described above for P. xylostella (Fig. 2 and Supplementary Table 3). For each of these three
strains, the resistance ratio was lower for modified toxins than for the corresponding native
toxins (Fig. 2). The lower resistance ratios for modified toxins than for their native counterparts seen with the four resistant strains described above are similar to previously reported results with P. gossypiella7 and Trichoplusia ni10 (Fig. 2).
To better understand the reductions in resistance ratio for modified toxins relative to
native toxins, we evaluated the potency of toxins, which is inversely related to the LC50
value.23 We calculated the potency ratio of each modified toxin as the LC50 of a native toxin
divided by the LC50 of the corresponding modified toxin. This analysis shows that the reductions in resistance ratio for modified toxins relative to native toxins occurred because
modified toxins were more potent than native toxins against resistant strains in four of six
cases and less potent than native toxins against susceptible strains in all cases (Fig. 3 and
Supplementary Table 4). For example, against the resistant strain of P. xylostella, potency
was >350-fold higher for Cry1AbMod than for Cry1Ab, and >540-fold higher for Cry1AcMod than for Cry1Ac. However, against the susceptible strain of P. xylostella, each modified toxin was less potent than the corresponding native toxin. Although Cry1AbMod was
significantly more potent than Cry1Ab against the resistant strain of D. saccharalis (P < 0.05,
Supplementary Table 3), we do not know if the observed 2.8-fold difference in potency
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would substantially enhance control. In two exceptions to the trend that potency against
resistant strains was higher for modified toxins than native toxins, Cry1AcMod was less
potent than Cry1Ac against resistant strains of H. armigera and D. saccharalis (Fig. 3 and
Supplementary Table 4).

Figure 3. Potency of modified Bt toxins relative to native Bt toxins. Data are reported here
for P. xylostella (Px), O. nubilalis (On), D. saccharalis (Ds), and H. armigera (Ha) (Supplementary Table 3) and were reported previously for P. gossypiella (Pg)7 and T. ni (Tn).10
Potency ratio is the LC50 of a native toxin divided by the LC50 of the corresponding modified toxin for a resistant strain (dark bars) or a susceptible strain (light bars). Values >1
indicate the modified toxin was more potent than the native toxin. Values <1 indicate the
native toxin was more potent than the modified toxin. The arrows pointing up indicate
potency ratios higher than the top of the bar that cannot be estimated precisely because
mortality of the resistant strains of Px and Pg against native toxins was so low that we
could not accurately estimate LC50 values.

In addition to the tests evaluating mortality described above, we examined growth inhibition in a susceptible strain and three laboratory-selected strains of H. virescens with
different levels and mechanisms of resistance to Cry1Ac: the YFO strain had relatively low
cadherin-based resistance, the YEE strain had higher resistance based on an ABC transporter mutation and the YHD3 strain had the highest level of resistance based on both
cadherin and ABC transporter mutations.24 We estimated resistance ratios for these strains
based on the toxin concentration causing 50% larval growth inhibition (IC50). Relative to
Cry1Ac, Cry1AcMod reduced the resistance ratio by a factor of >990 for YHD3 and ~100
for YFO (Supplementary Table 5). YEE was highly resistant to both Cry1Ac and Cry1AcMod (Supplementary Table 5). Based on IC50 values and growth inhibition at the highest
toxin concentration tested against each strain, Cry1AcMod was more potent than Cry1Ac
against YHD3, but Cry1AcMod was less potent than Cry1Ac against YEE, YFO and the
susceptible strain (Supplementary Tables 5–7).
The results here refute the hypothesis that Cry1AbMod and Cry1AcMod are more effective than native toxins if and only if resistance is caused by mutations in genes encoding
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toxin-binding cadherin proteins. Cry1AcMod was not more effective than Cry1Ac against
two strains in which resistance was caused primarily by a mutant cadherin allele: the SCDr1 strain of H. armigera18 and the YFO strain of H. virescens24 (Fig. 2 and Supplementary
Tables 4, 6 and 7). These results indicate that the modified toxins do not always effectively
counter resistance caused by cadherin mutations. Furthermore, one or both of the modified
toxins were more potent than their native counterparts against several strains in which
resistance was conferred primarily or entirely by other mutations. Field-selected resistance
in the NO-QAGE strain of P. xylostella and related strains is genetically linked with a mutation in a locus encoding an ABC transporter protein and not with the cadherin locus.19,25
Results here confirm and extend the idea that resistance in NO-QAGE does not involve
altered cadherin. Western blot analysis shows that an anti-cadherin antibody detected a
210-kD protein in NO-QAGE and in a susceptible strain of P. xylostella (Supplementary
Fig. 1). In contrast, we found that in P. gossypiella, an anti-cadherin antibody detected a
180-kD protein in a susceptible strain, but not in a strain that has cadherin-based resistance
(Supplementary Fig. 1).
For the resistant strain (KS) of O. nubilalis, analysis of its parent strain (SKY) shows that
the resistance is associated with mutations in a gene encoding an aminopeptidase P, but
not with mutations that alter cadherin or aminopeptidases N.26,27 Similar to the results described above for NO-QAGE, blots with anti-cadherin antibody detected no difference between resistant and susceptible strains of O. nubilalis in the quantity or size of cadherin
bands.26 In the Bt-RR strain of D. saccharalis, the resistance is associated with reduced expression of three aminopeptidase N genes and cadherin, but not with mutations in the
genes encoding these proteins.28,29 In addition, previous work showed the efficacy of the
modified toxins against a greenhouse-selected resistant strain of T. ni.10 Recent results indicate that this resistance is associated with reduced transcription of an aminopeptidase
(APN1) and is linked with an ABC transporter gene, but not with genes encoding either
cadherin or APN1 (refs. 25, 30). Against the three resistant strains of H. virescens, Cry1AcMod
was more potent than Cry1Ac against the highly resistant YHD3 strain with both cadherin
and ABC transporter mutations, but not against the two other resistant strains that had
either a cadherin mutation or an ABC transporter mutation.
Overall, in evaluations of mortality in six cases with paired resistant and susceptible
strains reported here (Figs. 2 and 3) and in four cases reported previously,7,10 the potency
ratio of the modified toxin relative to its native counterpart was positively correlated with
the resistance ratio for the native toxin (Spearman’s rank correlation, rs = 0.97, d.f. = 8, P < 0.0001;
Methods section). A similar trend occurred in the evaluations of growth inhibition for three
resistant strains of H. virescens: the potency of Cry1AcMod relative to Cry1Ac was highest
for the most resistant strain, YHD3 (Supplementary Tables 5–7). Thus, the evaluations
based on either mortality or growth inhibition indicate that the relative potency of the
modified toxins was generally higher against the strains most resistant to native toxins,
independent of the presence or absence of cadherin mutations. In one exception to this
pattern, Cry1AcMod was not more potent than Cry1Ac against the YEE strain of H. virescens,
which had a resistance ratio of >2,400 for Cry1Ac (Supplementary Tables 5–7). In sum, the
modified toxins provided an alternative pathway to toxicity that was substantially more
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potent than the natural pathway in most instances when the natural pathway was severely
disrupted.
The higher potency of modified toxins compared to native toxins against several resistant strains, including results from 21-d bioassays with P. gossypiella,7 indicates that stability is probably not lower for modified toxins than for native toxins. When P. gossypiella
larvae were exposed to Cry1Ac for 11 d and then transferred to an untreated diet, they
survived and pupated.17 Thus, the >90-fold higher potency of modified toxins over native
toxins against resistant P. gossypiella in 21-d bioassays implies sustained toxicity of the
modified toxins. Moreover, banding patterns resulting from digestion with insect midgut
juice or trypsin (Supplementary Fig. 2) and other traits are similar for modified and native
toxins.22
Based on the results reported here and previously,7,10 the potency of at least one modified toxin was higher than its native counterpart for six of nine resistant strains tested.
These six resistant strains represent six species from four families of Lepidoptera (Crambidae, Gelechiidae, Noctuidae and Plutellidae) in which resistance evolved in the laboratory,
greenhouse or field. Modified toxins were more potent than native toxins against these
resistant strains, yet native toxins were more potent against all susceptible strains tested.
Although we do not know if the modified toxins will be useful in the field, the results
suggest that it might be worthwhile to test combinations of modified toxins with native
Cry1A, Cry2 or Vip toxins.31 To assess the joint use of modified and native toxins, it must
be determined if they act independently, antagonistically, or synergistically.23 Insects can
probably adapt to modified Bt toxins used alone or in combination with other toxins.
Nonetheless, along with other control tactics32 and toxins that have been used less extensively than Cry1A toxins,33 the modified toxins may broaden the options for managing
some pests.
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Methods
Toxins
We tested the protoxin form of four toxins: Cry1Ab, Cry1Ac, Cry1AbMod, and Cry1AcMod.
Toxins were produced as described previously.7 We tailored cry1Ab and cry1Ac genes to
create the modified genes cry1AbMod and cry1AcMod using a three-step PCR process.7
Based on the coding sequences, Cry1AbMod and Cry1AcMod proteins are expected to lack
56 amino acids at the N terminus compared with Cry1Ab and Cry1Ac. In addition to lacking all of the amino acids of helix α-1 of domain I, Cry1AbMod and Cry1AcMod lack four
of the ten amino acids of helix α-2a (52-GAGF-55) and have two amino acid substitutions
in helix α-2a (57-58VL changed to MA) to provide a methionine for translation. As expected,
the Cry1AbMod and Cry1AcMod protoxins were ~125 kD, and Cry1Ab and Cry1Ac protoxins were ~130 kD.7
Insect strains
Supplementary Table 1 lists the resistant and susceptible insect strains of six species used
in this study (P. xylostella, O. nubilalis, D. saccharalis, H. armigera, H. virescens, and P. gossypiella)
and one species examined in previous work (T. ni10). All susceptible strains were reared in
the laboratory without exposure to Bt toxins or other insecticides. The origins of each strain
tested in this study are described below.
P. xylostella
We tested a resistant strain (NO-QAGE) and a susceptible strain (Geneva 88) of the global
vegetable pest, P. xylostella (diamondback moth), which is the first insect that evolved resistance to Bt toxins in open field populations.34,35 The susceptible strain (Geneva 88) originated in 1988 from a cabbage field near Geneva, New York.36 The NO-QAGE strain was
derived from a field population in Hawaii that evolved resistance to Bt sprays containing
Cry1Ab, Cry1Ac, and other Bt toxins.35 In this strain, resistance is associated with reduced
toxin binding to larval midgut membranes, and a major gene confers resistance to at least
five Bt toxins including Cry1Ab and Cry1Ac.35,37 Complementation tests show that the genetic locus conferring resistance in NO-QAGE also confers resistance in at least three other
field-selected strains of P. xylostella from the continental US and Asia.37,38 Our group35 created the resistant strain used here (NO-QAGE) by crossing NO-QA, a field-selected resistant strain from Hawaii38, with the susceptible strain Geneva 88, followed by selection
of the F3 progeny with Cry1Ac.
O. nubilalis
The resistant strain (KS) originated from a field collection of 126 diapausing larvae from
non-Bt corn in Kandiyohi County, Minnesota, in 2001. Of these 126 larvae, 14 that survived
exposure to a diagnostic Cry1Ab concentration were used to start the resistant strain
SKY.39,40 The resistant SKY insects were backcrossed with a susceptible strain (KY) that
originated from the same collection, allowed to mate, and the progeny were selected with
Cry1Ab.40–43 The resistant survivors from this reselection were subjected to a second cycle
of backcrossing, mating, and selection with Cry1Ab. The survivors were used to start the
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KS strain. The susceptible strain (ELS) was established in 1993 from ~500 O. nubilalis larvae
collected in the Lombardia region of northern Italy. In previous work, the ELS strain was
called I42, Europe-S26,43 and Els41.
D. saccharalis
The susceptible strain (Bt-SS) was established using larvae collected from corn fields near
Winnsboro in northeastern Louisiana during 2004. A Bt-resistant strain (Bt-RR) was developed from a single isoline family using an F2 screen.44 Bt-RR larvae completed development
on commercial Cry1Ab corn hybrids.44 Before the current study, the Bt-RR strain was backcrossed three times with the Bt-SS strain and reselected for resistance with Cry1Ab corn
leaf tissue in the F2 generation after each backcross.
H. armigera
The susceptible strain of H. armigera (SCD) originated from the Cote D’Ivoire in the 1970s
and was obtained from Bayer Crop Science in 2001. Yang et al. (ref. 18) created the resistant
strain (SCD-r1) by introgressing a mutant cadherin allele (r1) from the resistant GYBT
strain into the SCD strain by means of repeated backcrossing and selection. The GY strain
was started in August 2001 with 300 larvae collected from late season Bt cotton in Gaoyang
County, Hebei Province, China.45 GYBT was derived from GY by 28 generations of selection with larvae exposed by diet surface overlay to activated Cry1Ac toxin.45
H. virescens
The susceptible strain (CNW) originated from field collections in North Carolina and was
obtained in 1999 from the Department of Entomology Insectary at North Carolina State
University. The resistant YHD2 strain was started with eggs collected from seven tobacco
fields in Yadkin County, North Carolina, in 1988 and was the second replicate selected in
the laboratory with Cry1Ac, which was obtained initially from Bt subspecies kurstaki strain
HD73 (ref. 46). The resistant YHD3 strain was created by crossing YHD2 with the susceptible strain CNW and selecting with Cry1Ac24. YHD3 was homozygous for resistant alleles
at two separate loci, one encoding a cadherin protein (BtR-4) and the other an ABC transporter protein (BtR-6). One group24 used crosses with the CNW strain followed by markerassisted selection to create two less resistant strains: a moderately resistant strain (YEE)
that had only the ABC transporter resistance alleles and was reared on diet with 50 μg
Cry1Ac per ml diet; and the least resistant strain (YFO), which had only the cadherin resistance alleles and could be reared on diet with at most 5 μg Cry1Ac per ml diet.
P. gossypiella
The susceptible APHIS-S strain of P. gossypiella was derived in 1997 from the APHIS strain
reared at the USDA-APHIS Pink Bollworm Rearing Facility in Phoenix, Arizona.32 The
APHIS strain was started with insects collected from Arizona more than 30 years ago and
had been infused yearly with wild individuals before the APHIS-S strain was started. The
resistant AZP-R strain was started in 1997 by collecting individuals from ten cotton fields
in Arizona and selecting their progeny with various concentrations of Cry1Ac in the diet.47
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Bioassays
We used established bioassay techniques for each species. All bioassays were done in the
laboratory with larvae tested individually on diet. We either put toxins on the surface of
diet in wells of bioassay trays (diet surface overlay; P. xylostella, O. nubilalis, and H. armigera) or mixed toxins into diet (diet incorporation; D. saccharalis and H. virescens). All bioassays involved diet with a series of 5 to 8 toxin concentrations, including controls with no
toxin added. The total number of larvae tested for each combination of insect strain and
toxin ranged from 240 to 1,529 (Supplementary Table 1). We conducted replicates on two
or more dates for 10 of the 12 strains tested in bioassays. We replicated bioassays with the
CNW and YEE strains of H. virescens only on one date. Toxins and diet from two or more
separate batches were tested on separate dates in bioassays with P. xylostella, D. saccharalis,
and H. armigera. In nearly all bioassays, the experimenters did not know the identity of the
toxins until after the results were recorded.
We cannot exclude the possibility that variation among species in bioassay methods
(including differences in the age of larvae when bioassays started), affected the extent of
differences between conspecific strains (resistance ratios) and between proteins within a
strain (potency ratios). However, we suspect that such effects were relatively minor and
did not alter qualitative conclusions. Moreover, in the comparisons among three resistant
strains of H. virescens with different sets of mutations conferring resistance, bioassay methods were identical across strains, including age of larvae, method of exposure and environment. Summaries of the bioassay methods and relevant references for each species are
provided below.
P. xylostella
We used diet surface overlay bioassays to test third instars, with one larva per well of 128well plastic bioassay trays.35 Fifty μl of water containing 0.005% Triton X-100 and an appropriate amount of Bt toxin were added to each well. Mortality was recorded after 6 d at
27°C, 14L:10D.
O. nubilalis
We used diet surface overlay bioassays to test neonates (< 24 h old) individually in 128well trays.48 Thirty μl of water containing 0.1% Triton X-100 and an appropriate amount of
Bt toxin were added to each well. After 7 d at 27°C, 24 D, and 80% RH, larvae were scored
as dead if they died or if they had not grown beyond the first instar and did not weigh
> 0.1 mg.
D. saccharalis
We used diet incorporation bioassays to test neonates (< 24 h old).49 Toxins were diluted
with distilled water and mixed with diet. We added ~0.7 ml of diet into each well of a 32well plate and put one neonate in each well. After 7 d at 28°C, 16L:8D, and 50% RH, larvae
were scored as dead if they died or if they weighed ≤ 0.1 mg based on visual estimation.
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H. armigera
We used diet surface overlay bioassays to test second instars that had been starved for 4 h.18
Toxins were diluted with PBS (0.01 M, pH 7.4). We put 900 μl of liquid artificial diet in
each well of a 24-well plate. After the diet cooled and solidified, 100 μl of PBS with an
appropriate concentration of toxin was added to each well and allowed to air dry. We put
one second instar in each well. After 5 d at 26 ± 1°C, 16L:8D and 60% RH, larvae were
scored as dead if they died or if they weighed < 5 mg.
H. virescens
We used diet incorporation bioassays to test neonates (< 24 h old) individually in 2-ml
plastic vials, with one gram of diet per vial.50 After diet cooled to 50°C, toxin was mixed
into diet with a Cuisinart Quick Prep motorized mixer. Larvae were weighed after 6 d at
27°C, 16L:8D, 60% RH.
Data analysis
For all species except H. virescens, we used probit analysis of mortality data to estimate the
concentration of toxin killing 50% of larvae (LC50) and its 95% fiducial limits (FL), as well
as the slope of the concentration-mortality line and its standard error (s.e.m.). For H. virescens,
we performed a parallel probit analysis of weight data to estimate the toxin concentration
causing IC50, 95% FL, slope and s.e.m. We estimated the IC50 as the toxin concentration in
diet yielding larval weight that is 50% of the mean larval weight of the same strain reared
on diet without toxin (control). Probit analysis was done with SAS51 for P. xylostella, H. virescens,
and D. saccharalis; POLO-PC52 for O. nubilalis; and PoloPlus53 for H. armigera.
In cases where insects were so resistant that the LC50 (or IC50) could not be estimated
from probit analysis because of low mortality (or low growth inhibition), we inferred that
the LC50 (or IC50) was greater than the highest concentration tested. For example, with resistant P. xylostella, the highest concentration of Cry1Ab tested (100,000 ng toxin per well)
killed only 3.1% of larvae. Thus, we inferred that the LC50 was > 100,000 ng toxin per well.
We calculated the resistance ratio as the LC50 (or IC50) for a resistant strain divided by
the corresponding LC50 (or IC50) for the conspecific susceptible strain. We calculated the
reduction in resistance ratio for modified toxins as the resistance ratio for the native toxin
divided by the resistance ratio for the corresponding modified toxin. Potency is inversely
related to LC50 or IC50 (ref. 23). We calculated the potency ratio as the LC50 (or IC50) of the
native toxin divided by the LC50 (or IC50) of the corresponding modified toxin. We considered values of LC50 (or IC50) significantly different if their 95% FL did not overlap, which is
a conservative criterion.54
For H. virescens we used analysis of variance (ANOVA)51 to compare larval growth inhibition of Cry1AcMod versus Cry1Ac for each of three resistant strains and one susceptible strain. For the two resistant strains of H. virescens (YHD3 and YFO) that were tested in
two independent trials on different dates (Trials 1 and 2, Supplementary Table 7) we compared the results between trials with two-way ANOVA. For YHD3, this showed significant
effects of Trial and Trial X Toxin interaction, so we analyzed each trial separately with oneway ANOVA. For YFO, effects of Trial and Trial X Toxin interaction were not significant,
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so we used two-way ANOVA to analyze data jointly from Trials 1 and 2. We used Spearman’s rank correlation test (http://faculty.vassar.edu/lowry/VassarStats.html; accessed June
4, 2011) to evaluate the association between the resistance ratio for the modified toxin and
the potency of the modified toxin relative to its native counterpart for the six cases studied
here and four cases studied previously in which both the resistance ratio and potency ratio
were calculated from mortality data (Supplementary Tables 2–4).
Preparation of BBMV
Midguts of fourth instar P. xylostella and P. gossypiella were dissected and used to prepare
brush border membranes vesicles (BBMVs) by differential precipitation using MgCl2 (ref. 55)
and stored at −70°C until use.
Cadherin western blots
For detecting cadherin with anti-cadherin antibodies, BBMVs were prepared in the presence of 5 mM CaCl2. Ten micrograms of BBMVs were separated by 10% SDS-PAGE and
electrotransferred to PVDF membrane. For P. xylostella, an anti-cadherin antibody raised
against H. virescens cadherin56 (1:10,000) and secondary anti-rabbit (1:5,000) conjugated
with horseradish peroxidase For P. gossypiella, membranes were incubated with an antibody (anti-CR8-11) that recognizes a portion of P. gossypiella cadherin57 (1:30,000) and secondary anti-rabbit (1:5,000) antibody conjugated with horseradish peroxidase.
Stability of Cry1Ab, Cry1AbMod, and Cry1Ab Mutant Y110E after digestion with insect
midgut juice or trypsin
Cry1Ab mutant Y110E had a single amino acid change (tyrosine to glutamic acid) in position d of helix alpha-3 generated by site-directed mutagenesis.58 We activated 20 μg of each
toxin by incubation for 1 h at 37°C with 10 μg of midgut juice from M. sexta or 4 μg of
trypsin. Phenylmethylsulfonyl fluoride (1 mM final concentration) was added to stop proteolysis. The samples were separated by 10% SDS-PAGE and stained with Coomasie blue.
To obtain midgut juice, we dissected midgut tissue from fifth instar M. sexta larvae and
separated the midgut juice from solid material by centrifugation followed by filtering
through 0.22 μm filters. Total protein was determined by the Bradford assay and small
aliquots of midgut juice were stored at −70°C until use.
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Supplementary Table 1. Resistant and susceptible strains tested with modified and native Bt toxins.
_____________________________________________________________________________
Insect
Strain
Strain Genetic basis
Reference(s)
species
name
typea of resistance
_____________________________________________________________________________
P. xylostella

NO-QAGE
Geneva 88

R
S

mutant ABCb, not cadherin or APNc 19, 25, 35-38

O. nubilalis

KS
ELS

R
S

mutant APPd, not cadherin or APN

26, 27, 43

D. saccharalis

Bt-RR
Bt-SS

R
S

reduced expression of cadherin
and three APNs

28, 29, 44

H. armigera

SCD-r1
SCD

R
S

mutant cadherin

18

H. virescens

YFO
YEE
YHD3
CNW

R
R
R
S

mutant cadherin
mutant ABC
mutant ABC and cadherin

24
24
24

P. gossypiellae

AZP-R
APHIS-S

R
S

mutant cadherin

17

T. nif

GipBtR
R
mutant ABC
10, 30
GipS
S
reduced APN expressiong
_____________________________________________________________________________
a
R: resistant, S: susceptible
b

ABC transporter protein

c

aminopeptidase N

d

aminopeptidase P

e

Bioassay results with modified and native toxins reported previously7, new results from Western

blots for cadherin detection are reported here (Supplementary Figure 1).
f

Bioassay results with modified and native toxins reported previously10.

g

Complementation test results show that the mutation(s) in the Glen resistant strain of T. ni reducing

APN expression are allelic with the mutation(s) in the GipBtR strain (P. Wang pers. comm).

2

Supplementary Table 2. Reduction in resistance ratio for modified toxins relative to native
toxins against Plutella xylostella, based on mortality of resistant (R) and susceptible (S)
strains.
__________________________________________________________________________
b

Resistance
Reduction
Strain Toxin
n
Slope (SE)
LC50 (95% FL)
a
c
type
ratio (RR)
in RRd
__________________________________________________________________________
Plutella xylostella (concentration in ng toxin per well)
e
f
R
Cry1Ab
440
NA
>100,000
S
Cry1Ab
824
1.5 (0.1)
4.69 (3.7 – 20)

>21,000

R
S

Cry1AbMod 448
Cry1AbMod 816

4.0 (0.5)
1.1 (0.1)

288 (250 – 340)
92.7 (NA)

R
S

Cry1Ac
Cry1Ac

NA
2.4 (0.3)

>77,500
>110,000
0.713 (0.56 – 0.89)

384
416

3.1

>6900

g

R
Cry1AcMod 448
2.2 (0.3)
144 (110 – 180)
4.8
>23,000
S
Cry1AcMod 416
1.1 (0.1)
30.4 (20 – 49)
__________________________________________________________________________
a
R: resistant, S: susceptible; see Supplementary Table 1 for strain details.
b
c
d
e
f
g

Concentration killing 50% of larvae and its 95% fiducial limits in ng toxin per well
LC50 of resistant strain divided by LC50 of susceptible strain
Resistance ratio of native toxin divided by resistance ratio of its modified counterpart
Not available, could not be estimated
The highest concentration tested (100,000 ng toxin per well) killed only 3.1% of larvae.
The highest concentration tested (77,500 ng toxin per well) killed only 15.6% of larvae.

3

Supplementary Table 3. Reduction in resistance ratio for modified toxins relative to native
toxins against Ostrinia nubilalis, Diatraea saccharalis, and Helicoverpa armigera, based on
mortality of resistant (R) and susceptible (S) strains.
__________________________________________________________________________
b

Strain Toxin
n
Slope (SE)
LC50 (95% FL)
Resistance
Reduction
a
c
ratio (RR)
in RRd
type
__________________________________________________________________________
Ostrinia nubilalis (concentration in ng toxin per cm2 diet)
R
Cry1Ab
448
0.9 (0.2)
6640 (3200–21,000)
S
Cry1Ab
448
1.8 (0.2)
2.15 (0.48 – 14)
R
S

Cry1AbMod 384
Cry1AbMod 320

1.3 (0.1)
2.2 (0.3)

11.9 (8.3 – 16)
6.24 (3.6 – 13)

Diatraea saccharalis (concentration in μg toxin per g diet)
R
Cry1Ab
1042 1.4 (0.1)
13.7 (11 - 17)
S
Cry1Ab
1516 1.1 (0.1)
0.627 (0.45 - 0.88)

3100
1.9

22

R
S

Cry1AbMod 1072
Cry1AbMod 916

2.5 (0.2)
3.1 (0.3)

4.95 (4.2 - 5.9)
2.89 (2.5 - 3.4)

1.7

R
S

Cry1Ac
Cry1Ac

1529
936

1.5 (0.1)
2.0 (0.2)

0.387 (0.30 - 0.50)
0.0474 (0.038 - 0.057)

8.2

R
S

Cry1AcMod 1018
Cry1AcMod 1120

1.9 (0.3)
1.9 (0.2)

2.61 (1.9 - 3.6)
1.31 (0.99 - 1.7)

2.0

Helicoverpa armigera (concentration in ng toxin per cm2 diet)
R
Cry1Ac
471
2.2 (0.2)
1940 (1120 – 2820)
S
Cry1Ac
477
1.3 (0.1)
50 (8 – 110)

1600

13

4.1

39

R
Cry1AcMod 527
1.7 (0.1)
3650 (2280 – 5910)
2.2
18
S
Cry1AcMod 575
1.7 (0.1)
1660 (1310 – 2080)
__________________________________________________________________________
a
R: resistant, S: susceptible; see Supplementary Table 1 for strain details.
b
c
d

Concentration killing 50% of larvae and its 95% fiducial limits
LC50 of resistant strain divided by LC50 of susceptible strain
Resistance ratio of native toxin divided by resistance ratio of its modified counterpart

4

Supplementary Table 4. Potency ratio of modified Bt toxins for resistant and
susceptible strains of six major crop pests, calculated as the LC50 of a native toxin
divided by the LC50 of the corresponding modified toxin. Values >1 indicate the
modified toxin was more potent than the native toxin, which occurred for all resistant
strains below except Cry1AcMod relative to Cry1Ac for D. saccharalis and H.
armigera. Values <1 indicate the native toxin was more potent than modified toxin,
which occurred for all susceptible strains.
_________________________________________________________________
Species

Potency ratio
_______________________

Toxin pair

Resistant
Susceptible
strain
strain
_________________________________________________________________
P. xylostella

Cry1AbMod/Cry1Ab

>350

0.050

Cry1AcMod/Cry1Ac

>540

0.023

O. nubilalis

Cry1AbMod/Cry1Ab

560

0.32

D. saccharalis

Cry1AbMod/Cry1Ab

2.8

0.22

Cry1AcMod/Cry1Ac

0.15

0.036

H. armigera

Cry1AcMod/Cry1Ac

0.53

0.030

P. gossypiellaa

Cry1AbMod/Cry1Ab

>91

0.28

Cry1AcMod/Cry1Ac

>110

0.012

Cry1AbMod/Cry1Ab

53

0.48

T. nib

Cry1AcMod/Cry1Ac
11
0.069
_________________________________________________________________
a

Potency ratio based on previously reported data7.

b

Potency ratio based on previously reported data10.

5

Supplementary Table 5. Reduction in resistance ratio for Cry1AcMod relative to Cry1Ac against
Heliothis virescens, based on growth inhibition of resistant (R) and susceptible (S) strains.
_______________________________________________________________________________
Straina

Toxin

n

Slope (SE)

IC50 (95% FL)b

R: YHD3

Cry1Ac

312

NAe

>100f

>2400

R: YEE

Cry1Ac

300

NA

>100g

>2400

R: YFO

Cry1Ac

450

1.4 (0.3)

35.0 (19.3 – 85)

850

S: CNW

Cry1Ac

360

0.5 (0.1)

0.041 (0.001 - 0.22)

R: YHD3

Cry1AcMod 312

1.4 (0.5)

37.1 (13 – 220)

R: YEE

Cry1AcMod 300

NA

>100h

>6.6

NA

R: YFO

Cry1AcMod 450

NA

>100i

>6.6

100j

S: CNW

Cry1AcMod 360

2.1 (0.5)

15.1 (9.6 – 51)

Resistance
Reduction
c
ratio (RR)
in RRd
_______________________________________________________________________________

2.5

>990

_______________________________________________________________________________
a

R: resistant, S: susceptible; YHD3 had cadherin and ABC transporter protein mutations, YEE
had only the ABC transporter mutation, and YFO had only the cadherin mutation (Supplementary
Table 1)
b
Concentration causing 50% larval growth inhibition in µg toxin per ml diet (95% fiducial limits)
c
IC50 of resistant strain divided by IC50 of susceptible strain
d
Resistance ratio of Cry1Ac divided by resistance ratio of Cry1AcMod
e
Not available, could not be estimated
f
The highest concentration tested (100 µg Cry1Ac per ml diet) caused 7.4 to 15.5% growth
inhibition of YHD3 (Supplementary Table 7).
g
The highest concentration tested (100 µg Cry1Ac per ml diet) caused 18.0% growth inhibition of
YEE (Supplementary Table 7).
h
The highest concentration tested (100 µg Cry1AcMod per ml diet) caused 6.1% growth inhibition
of YEE (Supplementary Table 7).
i
The highest concentration tested (100 µg Cry1AcMod per ml diet) caused 48.6% growth
inhibition of YFO (Supplementary Table 7).
j
One hundred µg Cry1Ac per ml diet caused 48.6% growth inhibition, which is slightly less than
50% growth inhibition. If IC50 is estimated to be 100, the reduction in RR would be 130 (850/6.6).
If the IC50 is estimated to be slightly higher than 100 µg Cry1Ac per ml, the reduction in RR would
be slightly less than 130 (e.g., 850/7 = 121, 850/8 = 106). Because of this approximation, we
rounded the reduction in RR to 100, using just one significant digit. This conservative approach
may underestimate the reduction in RR.
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Supplementary Table 6. Potency ratio for modified Bt toxins against H. virescens,
calculated as the IC50 of Cry1Ac divided by the IC50 Cry1AcMod. The value of >2.7 for
YHD3 indicates the modified toxin was more potent than native toxin against this highly
resistant strain. The values <1 for YFO, YEE and CNW indicate the native toxin was
more potent than modified toxin against these strains.
_____________________________
Strain a
Potency ratio
_____________________________
R: YHD3

>2.7

R: YEE

<1b

R: YFO

<0.35

S: CNW
0.0027
______________________________
a

R: resistant, S: susceptible; see Supplementary Table 1 for strain details.
Although the potency ratio for YEE could not be estimated from IC50 values,
Cry1AcMod was significantly less potent than Cry1Ac based on responses at the highest
concentration tested (100 µg Cry1Ac per ml diet; Supplementary Table 7).
b
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Supplementary Table 7. Larval growth inhibition of resistant (R) and susceptible strains
of H. virescens caused by the highest concentrations tested of Cry1AcMod and Cry1Ac.
_________________________________________________________________________
Concn. Triala Growth
Pc
(µg/ml)
inhibition (%)b
_________________________________________________________________________

Strain Type

Toxin

YHD3 R: cadherin + ABC

Cry1AcMod 100
Cry1Ac
100

1
1

85.9 ± 1.1
15.5 ± 2.2

<0.0001

Cry1AcMod 100
Cry1Ac
100

2
2

64.7 ± 4.8
7.4 ± 10.1

<0.0001

Cry1AcMod 100
Cry1Ac
100

1
1

6.1 ± 1.8
18.0 ± 2.2

<0.0001

Cry1AcMod 100
Cry1Ac
100

1+2
1+2

48.6 ± 2.2
82.6 ± 1.1

<0.0001

YEE
YFO

R: ABC
R: cadherin

CNW Susceptible

Cry1AcMod 10
1
34.2 ± 6.3
Cry1Ac
10
1
98.0 ± 0.3
<0.0001
_________________________________________________________________________
a

Trial 1: n = 60 larvae per toxin per strain; Trial 2: n = 18 larvae per toxin per strain. For
YHD3, we found a significant difference in growth inhibition between Trials 1 and 2 and
thus analyzed data separately for each trial. For YFO, no significant difference occurred
between Trials and thus we analyzed data jointly for Trials 1 and 2 (see Online Methods
for details).
b

Growth inhibition (%) = (1 - [larval weight on treated diet/mean larval weight on control
diet]) X 100%, see Methods; values are means ± standard errors
c

Probability that the difference in growth inhibition between Cry1AcMod and Cry1Ac
occurred by chance, based on analysis of variance (ANOVA) (see Online Methods for
details).
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